SCHEMBL213868

SCHEMBL213868

CN1CC(=O)C(c2ccccc2)=N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.41
GABRG2 P18507 4/20 0.41
GABRB3 P28472 4/20 0.41
GABRA5 P31644 4/20 0.41
GABRA3 P34903 4/20 0.41
GABRA2 P47869 4/20 0.41
GABRB2 P47870 4/20 0.41
CCKBR P32239 1/20 0.41
CES2 O00748 2/20 0.38
ALDH1A1 P00352 4/20 0.37
APP P05067 1/20 0.37
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRA4 P48169 2/20 0.36
GABRE P78334 2/20 0.36
GABRA6 Q16445 2/20 0.36
GABRG1 Q8N1C3 2/20 0.36
GABRG3 Q99928 2/20 0.36
GABRQ Q9UN88 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11124893 0.77 KMT2A (0.39) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6836736 0.76 KDM4E (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3369625 0.74 ALDH1A1 (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
Dimethylamine SCHEMBL10491493 0.74 KDM4E (0.40) GABRA1GABRG2GABRB3GABRA5GABRA3
Diethylamine SCHEMBL10491539 0.70 CES2 (0.37) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8557689 0.68 HSD11B1 (0.39) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8559544 0.67 WDR5 (0.36) HSD11B1KDM4E
SCHEMBL6732619 0.63 ALDH1A1 (0.35) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL10683056 0.61 NR1H2 (0.42) KMT2ABRD4GAA
SCHEMBL4625694 0.61 GAA (0.54) CES2ALDH1A1APPMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7192455-B2 Process for dyeing keratin fibers with at least one ninhydrin derivative L'OREAL S.A. (FR) 2007-03-20 US claimed
US-7182790-B2 Use of at least one ninhydrin derivative for dyeing L'OREAL S.A. (FR) 2007-02-27 US claimed
EP-1200049-B1 AGENT FOR DYING KERATIN FIBERS HENKEL KGAA (DE) 2007-02-21 EP claimed
US-7179305-B2 Process for dyeing keratin fibers with ninhydrin compounds comprising one or more fused rings L'OREAL S.A. (FR) 2007-02-20 US claimed
US-7175671-B2 Use of ninhydrin derivatives bearing an unsaturated system for dyeing keratin material L'OREAL S.A. (FR) 2007-02-13 US claimed
EP-1235549-B1 AGENT FOR COLOURING KERATIN CONTAINING FIBRES HENKEL KGAA (DE) 2006-11-29 EP claimed
EP-1311231-B1 AGENT FOR COLOURING KERATIN-CONTAINING FIBRES COMPRISING AT LEAST ONE OXOCYCLOPENTENE DERIVATIVE HENKEL KGAA (DE) 2006-11-22 EP claimed
EP-1292271-B1 AGENT FOR DYEING FIBRES CONTAINING KERATIN HENKEL KGAA (DE) 2006-11-08 EP claimed
EP-1432428-B1 Agent for colouring fibres containing keratin HENKEL KGAA (DE) 2006-11-02 EP claimed
US-20060112499-A9 Process for dyeing keratin fibers with at least one ninhydrin derivative PLOS GREGORY 2006-06-01 US claimed
EP-0977545-A1 THE USE OF 1-SUBSTITUTED ISATINS TO DYE FIBERS CONTAINING KERATIN Henkel Kommanditgesellschaft auf Aktien (DE) 2000-02-09 EP claimed
EP-0977546-A1 USE OF UNSATURATED ALDEHYDES IN DYING FIBERS CONTAINING KERATIN Henkel Kommanditgesellschaft auf Aktien (DE) 2000-02-09 EP claimed
WO-1999018916-A2 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-04-22 WO claimed
WO-1999018914-A2 APPLICATION OF INDANONES FOR DYING FIBERS CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1999-04-22 WO claimed
WO-1998047473-A1 USE OF UNSATURATED ALDEHYDES IN DYING FIBERS CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1998-10-29 WO claimed
WO-1998047472-A1 THE USE OF 1-SUBSTITUTED ISATINS TO DYE FIBERS CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1998-10-29 WO claimed
EP-0873743-A2 Use of benzylidene-ketones for dyeing keratinous fibers Henkel Kommanditgesellschaft auf Aktien (DE) 1998-10-28 EP claimed
EP-0873744-A2 Use of heterocyclic carbonyl compounds for dying keratinous fibers Henkel Kommanditgesellschaft auf Aktien (DE) 1998-10-28 EP claimed
EP-0873746-A2 Dyestuff for keratinous fibers Henkel Kommanditgesellschaft auf Aktien (DE) 1998-10-28 EP claimed
EP-0873745-A2 Dyestuff for keratinous fibers Henkel Kommanditgesellschaft auf Aktien (DE) 1998-10-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060112499-A9 Process for dyeing keratin fibers with at least one ninhydrin derivative KRT18, DSG1, ACR GABRA1 4864/4885GABRG2 4855/4885GABRB3 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.